nodes	percent_of_prediction	percent_of_DWPC	metapath
Verteporfin—Oedema—Ifosfamide—testicular cancer	0.00239	0.00239	CcSEcCtD
Verteporfin—Vision blurred—Cisplatin—testicular cancer	0.00237	0.00237	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.00237	0.00237	CcSEcCtD
Verteporfin—Asthenia—Vinblastine—testicular cancer	0.00237	0.00237	CcSEcCtD
Verteporfin—Nervous system disorder—Ifosfamide—testicular cancer	0.00234	0.00234	CcSEcCtD
Verteporfin—Ill-defined disorder—Cisplatin—testicular cancer	0.00234	0.00234	CcSEcCtD
Verteporfin—Anaemia—Cisplatin—testicular cancer	0.00233	0.00233	CcSEcCtD
Verteporfin—Skin disorder—Ifosfamide—testicular cancer	0.00232	0.00232	CcSEcCtD
Verteporfin—Hyperhidrosis—Ifosfamide—testicular cancer	0.00231	0.00231	CcSEcCtD
Verteporfin—Feeling abnormal—Bleomycin—testicular cancer	0.0023	0.0023	CcSEcCtD
Verteporfin—Osteoarthritis—Methotrexate—testicular cancer	0.0023	0.0023	CcSEcCtD
Verteporfin—Malaise—Cisplatin—testicular cancer	0.00227	0.00227	CcSEcCtD
Verteporfin—Photosensitivity—Doxorubicin—testicular cancer	0.00226	0.00226	CcSEcCtD
Verteporfin—Dermatitis bullous—Epirubicin—testicular cancer	0.00225	0.00225	CcSEcCtD
Verteporfin—Back pain—Etoposide—testicular cancer	0.00223	0.00223	CcSEcCtD
Verteporfin—Pain—Dactinomycin—testicular cancer	0.00223	0.00223	CcSEcCtD
Verteporfin—Urticaria—Bleomycin—testicular cancer	0.00222	0.00222	CcSEcCtD
Verteporfin—Eczema—Doxorubicin—testicular cancer	0.00221	0.00221	CcSEcCtD
Verteporfin—Body temperature increased—Bleomycin—testicular cancer	0.00221	0.00221	CcSEcCtD
Verteporfin—Dizziness—Vinblastine—testicular cancer	0.00219	0.00219	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.00217	0.00217	CcSEcCtD
Verteporfin—Diplopia—Epirubicin—testicular cancer	0.00215	0.00215	CcSEcCtD
Verteporfin—Osteoarthritis—Epirubicin—testicular cancer	0.00215	0.00215	CcSEcCtD
Verteporfin—Feeling abnormal—Dactinomycin—testicular cancer	0.00214	0.00214	CcSEcCtD
Verteporfin—Nausea—Chlorambucil—testicular cancer	0.00214	0.00214	CcSEcCtD
Verteporfin—Ill-defined disorder—Etoposide—testicular cancer	0.00214	0.00214	CcSEcCtD
Verteporfin—Anaemia—Etoposide—testicular cancer	0.00213	0.00213	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.00213	0.00213	CcSEcCtD
Verteporfin—Dyspnoea—Ifosfamide—testicular cancer	0.00213	0.00213	CcSEcCtD
Verteporfin—Liver function test abnormal—Methotrexate—testicular cancer	0.00212	0.00212	CcSEcCtD
Verteporfin—Discomfort—Cisplatin—testicular cancer	0.00212	0.00212	CcSEcCtD
Verteporfin—Malaise—Etoposide—testicular cancer	0.00208	0.00208	CcSEcCtD
Verteporfin—Dermatitis bullous—Doxorubicin—testicular cancer	0.00208	0.00208	CcSEcCtD
Verteporfin—Vertigo—Etoposide—testicular cancer	0.00207	0.00207	CcSEcCtD
Verteporfin—Headache—Vinblastine—testicular cancer	0.00207	0.00207	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00206	0.00206	CcSEcCtD
Verteporfin—Body temperature increased—Dactinomycin—testicular cancer	0.00206	0.00206	CcSEcCtD
Verteporfin—Oedema—Cisplatin—testicular cancer	0.00206	0.00206	CcSEcCtD
Verteporfin—Hypersensitivity—Bleomycin—testicular cancer	0.00206	0.00206	CcSEcCtD
Verteporfin—Pain—Ifosfamide—testicular cancer	0.00204	0.00204	CcSEcCtD
Verteporfin—Constipation—Ifosfamide—testicular cancer	0.00204	0.00204	CcSEcCtD
Verteporfin—Loss of consciousness—Etoposide—testicular cancer	0.00203	0.00203	CcSEcCtD
Verteporfin—Nervous system disorder—Cisplatin—testicular cancer	0.00202	0.00202	CcSEcCtD
Verteporfin—Cough—Etoposide—testicular cancer	0.00201	0.00201	CcSEcCtD
Verteporfin—Blood creatinine increased—Epirubicin—testicular cancer	0.00201	0.00201	CcSEcCtD
Verteporfin—Asthenia—Bleomycin—testicular cancer	0.002	0.002	CcSEcCtD
Verteporfin—Skin disorder—Cisplatin—testicular cancer	0.002	0.002	CcSEcCtD
Verteporfin—Hypertension—Etoposide—testicular cancer	0.00199	0.00199	CcSEcCtD
Verteporfin—Diplopia—Doxorubicin—testicular cancer	0.00199	0.00199	CcSEcCtD
Verteporfin—Osteoarthritis—Doxorubicin—testicular cancer	0.00199	0.00199	CcSEcCtD
Verteporfin—Hyperhidrosis—Cisplatin—testicular cancer	0.00199	0.00199	CcSEcCtD
Verteporfin—Liver function test abnormal—Epirubicin—testicular cancer	0.00198	0.00198	CcSEcCtD
Verteporfin—Pruritus—Bleomycin—testicular cancer	0.00197	0.00197	CcSEcCtD
Verteporfin—Feeling abnormal—Ifosfamide—testicular cancer	0.00197	0.00197	CcSEcCtD
Verteporfin—Chest pain—Etoposide—testicular cancer	0.00197	0.00197	CcSEcCtD
Verteporfin—Nausea—Vinblastine—testicular cancer	0.00196	0.00196	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.00195	0.00195	CcSEcCtD
Verteporfin—Discomfort—Etoposide—testicular cancer	0.00194	0.00194	CcSEcCtD
Verteporfin—Hypersensitivity—Dactinomycin—testicular cancer	0.00192	0.00192	CcSEcCtD
Verteporfin—Muscular weakness—Epirubicin—testicular cancer	0.00189	0.00189	CcSEcCtD
Verteporfin—Urticaria—Ifosfamide—testicular cancer	0.00189	0.00189	CcSEcCtD
Verteporfin—Body temperature increased—Ifosfamide—testicular cancer	0.00189	0.00189	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00187	0.00187	CcSEcCtD
Verteporfin—Asthenia—Dactinomycin—testicular cancer	0.00187	0.00187	CcSEcCtD
Verteporfin—Blood creatinine increased—Doxorubicin—testicular cancer	0.00186	0.00186	CcSEcCtD
Verteporfin—Influenza—Epirubicin—testicular cancer	0.00186	0.00186	CcSEcCtD
Verteporfin—Liver function test abnormal—Doxorubicin—testicular cancer	0.00184	0.00184	CcSEcCtD
Verteporfin—Dyspnoea—Cisplatin—testicular cancer	0.00183	0.00183	CcSEcCtD
Verteporfin—Skin disorder—Etoposide—testicular cancer	0.00183	0.00183	CcSEcCtD
Verteporfin—Hyperhidrosis—Etoposide—testicular cancer	0.00182	0.00182	CcSEcCtD
Verteporfin—Photosensitivity reaction—Methotrexate—testicular cancer	0.00181	0.00181	CcSEcCtD
Verteporfin—Pneumonia—Methotrexate—testicular cancer	0.00178	0.00178	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00178	0.00178	CcSEcCtD
Verteporfin—Rash—Bleomycin—testicular cancer	0.00176	0.00176	CcSEcCtD
Verteporfin—Pain—Cisplatin—testicular cancer	0.00176	0.00176	CcSEcCtD
Verteporfin—Dermatitis—Bleomycin—testicular cancer	0.00176	0.00176	CcSEcCtD
Verteporfin—Hypersensitivity—Ifosfamide—testicular cancer	0.00176	0.00176	CcSEcCtD
Verteporfin—Muscular weakness—Doxorubicin—testicular cancer	0.00175	0.00175	CcSEcCtD
Verteporfin—Conjunctivitis—Methotrexate—testicular cancer	0.00172	0.00172	CcSEcCtD
Verteporfin—Influenza—Doxorubicin—testicular cancer	0.00172	0.00172	CcSEcCtD
Verteporfin—Asthenia—Ifosfamide—testicular cancer	0.00171	0.00171	CcSEcCtD
Verteporfin—Sweating—Methotrexate—testicular cancer	0.0017	0.0017	CcSEcCtD
Verteporfin—Photosensitivity reaction—Epirubicin—testicular cancer	0.00169	0.00169	CcSEcCtD
Verteporfin—Feeling abnormal—Cisplatin—testicular cancer	0.00169	0.00169	CcSEcCtD
Verteporfin—Pruritus—Ifosfamide—testicular cancer	0.00169	0.00169	CcSEcCtD
Verteporfin—Dyspnoea—Etoposide—testicular cancer	0.00168	0.00168	CcSEcCtD
Verteporfin—Pneumonia—Epirubicin—testicular cancer	0.00167	0.00167	CcSEcCtD
Verteporfin—Nausea—Bleomycin—testicular cancer	0.00166	0.00166	CcSEcCtD
Verteporfin—Rash—Dactinomycin—testicular cancer	0.00164	0.00164	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Etoposide—testicular cancer	0.00163	0.00163	CcSEcCtD
Verteporfin—Body temperature increased—Cisplatin—testicular cancer	0.00163	0.00163	CcSEcCtD
Verteporfin—Constipation—Etoposide—testicular cancer	0.00161	0.00161	CcSEcCtD
Verteporfin—Pain—Etoposide—testicular cancer	0.00161	0.00161	CcSEcCtD
Verteporfin—Conjunctivitis—Epirubicin—testicular cancer	0.00161	0.00161	CcSEcCtD
Verteporfin—Haemoglobin—Methotrexate—testicular cancer	0.0016	0.0016	CcSEcCtD
Verteporfin—Haemorrhage—Methotrexate—testicular cancer	0.00159	0.00159	CcSEcCtD
Verteporfin—Sweating—Epirubicin—testicular cancer	0.00159	0.00159	CcSEcCtD
Verteporfin—Dizziness—Ifosfamide—testicular cancer	0.00158	0.00158	CcSEcCtD
Verteporfin—Pharyngitis—Methotrexate—testicular cancer	0.00158	0.00158	CcSEcCtD
Verteporfin—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Verteporfin—Feeling abnormal—Etoposide—testicular cancer	0.00155	0.00155	CcSEcCtD
Verteporfin—Nausea—Dactinomycin—testicular cancer	0.00155	0.00155	CcSEcCtD
Verteporfin—Pneumonia—Doxorubicin—testicular cancer	0.00154	0.00154	CcSEcCtD
Verteporfin—Visual impairment—Methotrexate—testicular cancer	0.00153	0.00153	CcSEcCtD
Verteporfin—Hypersensitivity—Cisplatin—testicular cancer	0.00151	0.00151	CcSEcCtD
Verteporfin—Rash—Ifosfamide—testicular cancer	0.0015	0.0015	CcSEcCtD
Verteporfin—Dermatitis—Ifosfamide—testicular cancer	0.0015	0.0015	CcSEcCtD
Verteporfin—Urticaria—Etoposide—testicular cancer	0.0015	0.0015	CcSEcCtD
Verteporfin—Haemoglobin—Epirubicin—testicular cancer	0.00149	0.00149	CcSEcCtD
Verteporfin—Body temperature increased—Etoposide—testicular cancer	0.00149	0.00149	CcSEcCtD
Verteporfin—Conjunctivitis—Doxorubicin—testicular cancer	0.00149	0.00149	CcSEcCtD
Verteporfin—Haemorrhage—Epirubicin—testicular cancer	0.00149	0.00149	CcSEcCtD
Verteporfin—Eye disorder—Methotrexate—testicular cancer	0.00148	0.00148	CcSEcCtD
Verteporfin—Hypoaesthesia—Epirubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Verteporfin—Asthenia—Cisplatin—testicular cancer	0.00148	0.00148	CcSEcCtD
Verteporfin—Pharyngitis—Epirubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Verteporfin—Cardiac disorder—Methotrexate—testicular cancer	0.00147	0.00147	CcSEcCtD
Verteporfin—Sweating—Doxorubicin—testicular cancer	0.00147	0.00147	CcSEcCtD
Verteporfin—Angiopathy—Methotrexate—testicular cancer	0.00144	0.00144	CcSEcCtD
Verteporfin—Immune system disorder—Methotrexate—testicular cancer	0.00143	0.00143	CcSEcCtD
Verteporfin—Visual impairment—Epirubicin—testicular cancer	0.00143	0.00143	CcSEcCtD
Verteporfin—Nausea—Ifosfamide—testicular cancer	0.00142	0.00142	CcSEcCtD
Verteporfin—Eye disorder—Epirubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Verteporfin—Hypersensitivity—Etoposide—testicular cancer	0.00139	0.00139	CcSEcCtD
Verteporfin—Malnutrition—Methotrexate—testicular cancer	0.00138	0.00138	CcSEcCtD
Verteporfin—Haemoglobin—Doxorubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Verteporfin—Flushing—Epirubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Verteporfin—Cardiac disorder—Epirubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Verteporfin—Haemorrhage—Doxorubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Verteporfin—Hypoaesthesia—Doxorubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Verteporfin—Pharyngitis—Doxorubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Verteporfin—Asthenia—Etoposide—testicular cancer	0.00135	0.00135	CcSEcCtD
Verteporfin—Angiopathy—Epirubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Verteporfin—Immune system disorder—Epirubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Verteporfin—Back pain—Methotrexate—testicular cancer	0.00134	0.00134	CcSEcCtD
Verteporfin—Pruritus—Etoposide—testicular cancer	0.00133	0.00133	CcSEcCtD
Verteporfin—Visual impairment—Doxorubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Verteporfin—Vision blurred—Methotrexate—testicular cancer	0.0013	0.0013	CcSEcCtD
Verteporfin—Rash—Cisplatin—testicular cancer	0.0013	0.0013	CcSEcCtD
Verteporfin—Dermatitis—Cisplatin—testicular cancer	0.0013	0.0013	CcSEcCtD
Verteporfin—Malnutrition—Epirubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Verteporfin—Eye disorder—Doxorubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Verteporfin—Ill-defined disorder—Methotrexate—testicular cancer	0.00128	0.00128	CcSEcCtD
Verteporfin—Anaemia—Methotrexate—testicular cancer	0.00128	0.00128	CcSEcCtD
Verteporfin—Flushing—Doxorubicin—testicular cancer	0.00128	0.00128	CcSEcCtD
Verteporfin—Cardiac disorder—Doxorubicin—testicular cancer	0.00128	0.00128	CcSEcCtD
Verteporfin—Back pain—Epirubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Verteporfin—Angiopathy—Doxorubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Verteporfin—Malaise—Methotrexate—testicular cancer	0.00125	0.00125	CcSEcCtD
Verteporfin—Dizziness—Etoposide—testicular cancer	0.00125	0.00125	CcSEcCtD
Verteporfin—Immune system disorder—Doxorubicin—testicular cancer	0.00124	0.00124	CcSEcCtD
Verteporfin—Vertigo—Methotrexate—testicular cancer	0.00124	0.00124	CcSEcCtD
Verteporfin—Nausea—Cisplatin—testicular cancer	0.00122	0.00122	CcSEcCtD
Verteporfin—Vision blurred—Epirubicin—testicular cancer	0.00122	0.00122	CcSEcCtD
Verteporfin—Cough—Methotrexate—testicular cancer	0.00121	0.00121	CcSEcCtD
Verteporfin—Ill-defined disorder—Epirubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Verteporfin—Malnutrition—Doxorubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Verteporfin—Anaemia—Epirubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Verteporfin—Rash—Etoposide—testicular cancer	0.00119	0.00119	CcSEcCtD
Verteporfin—Dermatitis—Etoposide—testicular cancer	0.00119	0.00119	CcSEcCtD
Verteporfin—Headache—Etoposide—testicular cancer	0.00118	0.00118	CcSEcCtD
Verteporfin—Arthralgia—Methotrexate—testicular cancer	0.00118	0.00118	CcSEcCtD
Verteporfin—Chest pain—Methotrexate—testicular cancer	0.00118	0.00118	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00117	0.00117	CcSEcCtD
Verteporfin—Malaise—Epirubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Verteporfin—Discomfort—Methotrexate—testicular cancer	0.00116	0.00116	CcSEcCtD
Verteporfin—Vertigo—Epirubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Verteporfin—Syncope—Epirubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Verteporfin—Back pain—Doxorubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Verteporfin—Loss of consciousness—Epirubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Verteporfin—Cough—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Verteporfin—Vision blurred—Doxorubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Verteporfin—Nausea—Etoposide—testicular cancer	0.00112	0.00112	CcSEcCtD
Verteporfin—Hypertension—Epirubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Verteporfin—Ill-defined disorder—Doxorubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Verteporfin—Nervous system disorder—Methotrexate—testicular cancer	0.00111	0.00111	CcSEcCtD
Verteporfin—Anaemia—Doxorubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Verteporfin—Chest pain—Epirubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Verteporfin—Arthralgia—Epirubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Verteporfin—Skin disorder—Methotrexate—testicular cancer	0.0011	0.0011	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Verteporfin—Hyperhidrosis—Methotrexate—testicular cancer	0.00109	0.00109	CcSEcCtD
Verteporfin—Discomfort—Epirubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Verteporfin—Malaise—Doxorubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Verteporfin—Vertigo—Doxorubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Verteporfin—Syncope—Doxorubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Verteporfin—Oedema—Epirubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Verteporfin—Loss of consciousness—Doxorubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Verteporfin—Cough—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Verteporfin—Shock—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Verteporfin—Nervous system disorder—Epirubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
Verteporfin—Hypertension—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00103	0.00103	CcSEcCtD
Verteporfin—Skin disorder—Epirubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Verteporfin—Hyperhidrosis—Epirubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Verteporfin—Arthralgia—Doxorubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Verteporfin—Chest pain—Doxorubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Verteporfin—Discomfort—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Verteporfin—Dyspnoea—Methotrexate—testicular cancer	0.00101	0.00101	CcSEcCtD
Verteporfin—Oedema—Doxorubicin—testicular cancer	0.000977	0.000977	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000974	0.000974	CcSEcCtD
Verteporfin—Pain—Methotrexate—testicular cancer	0.000965	0.000965	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000962	0.000962	CcSEcCtD
Verteporfin—Shock—Doxorubicin—testicular cancer	0.000961	0.000961	CcSEcCtD
Verteporfin—Nervous system disorder—Doxorubicin—testicular cancer	0.000958	0.000958	CcSEcCtD
Verteporfin—Skin disorder—Doxorubicin—testicular cancer	0.000949	0.000949	CcSEcCtD
Verteporfin—Hyperhidrosis—Doxorubicin—testicular cancer	0.000945	0.000945	CcSEcCtD
Verteporfin—Dyspnoea—Epirubicin—testicular cancer	0.000941	0.000941	CcSEcCtD
Verteporfin—Feeling abnormal—Methotrexate—testicular cancer	0.00093	0.00093	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000912	0.000912	CcSEcCtD
Verteporfin—Pain—Epirubicin—testicular cancer	0.000903	0.000903	CcSEcCtD
Verteporfin—Constipation—Epirubicin—testicular cancer	0.000903	0.000903	CcSEcCtD
Verteporfin—Urticaria—Methotrexate—testicular cancer	0.000896	0.000896	CcSEcCtD
Verteporfin—Body temperature increased—Methotrexate—testicular cancer	0.000892	0.000892	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.00089	0.00089	CcSEcCtD
Verteporfin—Dyspnoea—Doxorubicin—testicular cancer	0.000871	0.000871	CcSEcCtD
Verteporfin—Feeling abnormal—Epirubicin—testicular cancer	0.00087	0.00087	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000844	0.000844	CcSEcCtD
Verteporfin—Urticaria—Epirubicin—testicular cancer	0.000839	0.000839	CcSEcCtD
Verteporfin—Constipation—Doxorubicin—testicular cancer	0.000836	0.000836	CcSEcCtD
Verteporfin—Pain—Doxorubicin—testicular cancer	0.000836	0.000836	CcSEcCtD
Verteporfin—Body temperature increased—Epirubicin—testicular cancer	0.000835	0.000835	CcSEcCtD
Verteporfin—Hypersensitivity—Methotrexate—testicular cancer	0.000831	0.000831	CcSEcCtD
Verteporfin—Asthenia—Methotrexate—testicular cancer	0.00081	0.00081	CcSEcCtD
Verteporfin—Feeling abnormal—Doxorubicin—testicular cancer	0.000805	0.000805	CcSEcCtD
Verteporfin—Pruritus—Methotrexate—testicular cancer	0.000798	0.000798	CcSEcCtD
Verteporfin—Hypersensitivity—Epirubicin—testicular cancer	0.000778	0.000778	CcSEcCtD
Verteporfin—Urticaria—Doxorubicin—testicular cancer	0.000776	0.000776	CcSEcCtD
Verteporfin—Body temperature increased—Doxorubicin—testicular cancer	0.000772	0.000772	CcSEcCtD
Verteporfin—Asthenia—Epirubicin—testicular cancer	0.000758	0.000758	CcSEcCtD
Verteporfin—Pruritus—Epirubicin—testicular cancer	0.000747	0.000747	CcSEcCtD
Verteporfin—Dizziness—Methotrexate—testicular cancer	0.000746	0.000746	CcSEcCtD
Verteporfin—Hypersensitivity—Doxorubicin—testicular cancer	0.00072	0.00072	CcSEcCtD
Verteporfin—Rash—Methotrexate—testicular cancer	0.000711	0.000711	CcSEcCtD
Verteporfin—Dermatitis—Methotrexate—testicular cancer	0.000711	0.000711	CcSEcCtD
Verteporfin—Headache—Methotrexate—testicular cancer	0.000707	0.000707	CcSEcCtD
Verteporfin—Asthenia—Doxorubicin—testicular cancer	0.000701	0.000701	CcSEcCtD
Verteporfin—Dizziness—Epirubicin—testicular cancer	0.000698	0.000698	CcSEcCtD
Verteporfin—Pruritus—Doxorubicin—testicular cancer	0.000691	0.000691	CcSEcCtD
Verteporfin—Nausea—Methotrexate—testicular cancer	0.00067	0.00067	CcSEcCtD
Verteporfin—Rash—Epirubicin—testicular cancer	0.000666	0.000666	CcSEcCtD
Verteporfin—Dermatitis—Epirubicin—testicular cancer	0.000665	0.000665	CcSEcCtD
Verteporfin—Headache—Epirubicin—testicular cancer	0.000662	0.000662	CcSEcCtD
Verteporfin—Dizziness—Doxorubicin—testicular cancer	0.000646	0.000646	CcSEcCtD
Verteporfin—Nausea—Epirubicin—testicular cancer	0.000627	0.000627	CcSEcCtD
Verteporfin—Rash—Doxorubicin—testicular cancer	0.000616	0.000616	CcSEcCtD
Verteporfin—Dermatitis—Doxorubicin—testicular cancer	0.000615	0.000615	CcSEcCtD
Verteporfin—Headache—Doxorubicin—testicular cancer	0.000612	0.000612	CcSEcCtD
Verteporfin—Nausea—Doxorubicin—testicular cancer	0.00058	0.00058	CcSEcCtD
